PBLS logo

Parabilis Medicines, Inc.

PBLS
Healthcare|Biotechnology|US
$28.53
+0.65 (+2.33%)
Tangible Book / Share
$36.24
Cash / Share
$38.77
Next Earnings Report
Nov 12, 2026
EPS est. -$0.36 · Revenue est. $375.0K
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Jun 10, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (1)

Apr 2027
Est. completion
P1P2Cancer
FOG-001 in Locally Advanced or Metastatic Solid Tumors
NCT05919264n=619

Recent Press Releases

Parabilis Medicines to Participate in Upcoming November Investor Conferences
Nov 3, 2026 · GlobeNewsWire
Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
Oct 24, 2026 · GlobeNewsWire
Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026
Oct 19, 2026 · GlobeNewsWire
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
Oct 14, 2026 · GlobeNewsWire
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 1, 2026 · GlobeNewsWire
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D.
Aug 25, 2026 · GlobeNewsWire
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 13, 2026 · GlobeNewsWire

SEC Filings (21)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 20268-KMaterial eventDocumentIndex
Sep 15, 20268-KMaterial eventDocumentIndex
Sep 2, 20268-KMaterial eventDocumentIndex
Aug 25, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 18, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Jun 11, 20268-KMaterial eventDocumentIndex
Jun 10, 2026S-8Employee stock planDocumentIndex
Jun 10, 2026424B4Offering prospectusDocumentIndex
Jun 10, 2026FWPDocumentIndex
Jun 9, 2026EFFECTDocumentIndex
Jun 9, 2026S-1MEFIPO / offering registrationDocumentIndex
Jun 9, 2026CERTDocumentIndex
Jun 9, 2026S-1/AIPO / offering registrationDocumentIndex
Jun 5, 20268-A12BDocumentIndex
Jun 4, 2026S-1/AIPO / offering registrationDocumentIndex
May 27, 2026S-1/AIPO / offering registrationDocumentIndex
May 19, 2026S-1IPO / offering registrationDocumentIndex